| Source: |
| Type: |
| Passive accumulation (in cells) is based on the unique architecture of the tumor tissue, where neo-angiogenesis leads to an atypical endothelial layer and to fenestrated vasculature, which together with the impaired lymphatic drainage guides the penetration and accumulation of nano-sized materials within the cancerous tissues. Exploited for drug design in the nanomedicine field. |
| 5977- | AgNPs, | CDT, | Silver Nitroprusside as an Efficient Chemodynamic Therapeutic Agent and a Peroxynitrite nanogenerator for Targeted Cancer Therapy |
| - | in-vivo, | Ovarian, | A2780S | - | NA, | Ovarian, | SKOV3 |
| 4403- | AgNPs, | Silver Nanoparticles Decorated UiO-66-NH2 Metal-Organic Framework for Combination Therapy in Cancer Treatment |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | GL26 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | CRC, | RKO |
| 4418- | AgNPs, | Nanocarriers for the topical treatment of psoriasis - pathophysiology, conventional treatments, nanotechnology, regulatory and toxicology |
| - | Human, | PSA, | NA |
| 4431- | AgNPs, | doxoR, | Oxidative Stress-Induced Silver Nano-Carriers for Chemotherapy |
| - | in-vitro, | BC, | 4T1 | - | in-vivo, | BC, | 4T1 | - | in-vitro, | Nor, | 3T3 |
| 4438- | AgNPs, | ART/DHA, | Biogenic synthesis of AgNPs using Artemisia oliveriana extract and their biological activities for an effective treatment of lung cancer |
| - | in-vitro, | Lung, | A549 |
| 4549- | AgNPs, | Silver nanoparticles: Synthesis, medical applications and biosafety |
| - | Review, | Var, | NA | - | Review, | Diabetic, | NA |
| - | in-vitro, | BC, | MCF-7 |
| 5146- | AgNPs, | Silver Nanoparticle-Induced Autophagic-Lysosomal Disruption and NLRP3-Inflammasome Activation in HepG2 Cells Is Size-Dependent |
| - | in-vitro, | Liver, | HepG2 |
| 5142- | AgNPs, | Biosynthesized Protein-Capped Silver Nanoparticles Induce ROS-Dependent Proapoptotic Signals and Prosurvival Autophagy in Cancer Cells |
| - | in-vitro, | CRC, | HUH7 |
| 5385- | AsP, | GoldNP, | GEM, | Development of ascorbyl palmitate based hydrophobic gold nanoparticles as a nanocarrier system for gemcitabine delivery |
| - | in-vitro, | BC, | NA |
| 5387- | AsP, | PacT, | Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy |
| - | in-vivo, | Melanoma, | B16-F10 |
| 5543- | BBM, | Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo |
| - | in-vivo, | Lung, | B16-F10 | - | vitro+vivo, | Lung, | A549 | - | in-vitro, | BC, | MDA-MB-231 |
| 5656- | BNL, | Role of borneol as enhancer in drug formulation: A review |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 5657- | BNL, | Enhancing effect and safety assessment of borneol on the oral absorption of sub-100 nm PLGA nanoparticles |
| - | in-vivo, | Nor, | NA |
| - | vitro+vivo, | GBM, | U251 |
| 5660- | BNL, | Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System |
| - | Review, | Var, | NA |
| 2015- | CAP, | CUR, | urea, | Anti-cancer Activity of Sustained Release Capsaicin Formulations |
| - | Review, | Var, | NA |
| 5983- | Chit, | Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy |
| - | Review, | BC, | NA |
| 5991- | Chit, | Chitosan-Based Nanoencapsulated Essential Oils: Potential Leads against Breast Cancer Cells in Preclinical Studies |
| - | Review, | BC, | NA |
| 5995- | Chit, | CUR, | Enhancement of anticancer activity and drug delivery of chitosan-curcumin nanoparticle via molecular docking and simulation analysis |
| - | vitro+vivo, | Var, | NA |
| 5994- | Chit, | Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action |
| - | Review, | Var, | NA |
| 5990- | Chit, | Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies |
| - | Review, | Var, | NA |
| 4490- | Chit, | FA, | Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives |
| - | Review, | NA, | NA |
| 4489- | Chit, | SeNPs, | Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy |
| - | in-vitro, | GBM, | U87MG |
| 4482- | Chit, | Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44 |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Liver, | HepG2 |
| 5519- | EP, | Nanosecond Pulsed Electric Fields (nsPEFs) for Precision Intracellular Oncotherapy: Recent Advances and Emerging Directions |
| - | Review, | Var, | NA |
| 5390- | GoldNP, | GEM, | AsP, | Optimizing Gold Nanoparticles for Combination Therapy: Development of Hydrophobic Nanomedical Devices with Gemcitabine and Ascorbyl Palmitate |
| - | in-vitro, | BC, | 4T1 |
| 3526- | GoldNP, | Rad, | Advances in nanoparticle-based radiotherapy for cancer treatment |
| - | Review, | Var, | NA |
| 3464- | MF, | Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology |
| - | Review, | Var, | NA |
| 497- | MF, | In Vitro and in Vivo Study of the Effect of Osteogenic Pulsed Electromagnetic Fields on Breast and Lung Cancer Cells |
| - | vitro+vivo, | NA, | MCF-7 | - | vitro+vivo, | NA, | A549 |
| 4472- | SeNPs, | Therapeutic potential of selenium nanoparticles |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:612 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid